Holocene Advisors
ABMD

Holocene Advisors’s Abiomed Inc ABMD Stock Holding History

Holocene Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-634
Closed -$206K – 1016
2021
Q3 		$206K Sell
634
-1,550
-71% -$525K ﹤0.01% 789
2021
Q2 		$682K Sell
2,184
-1,059
-33% -$325K ﹤0.01% 708
2021
Q1 		$1.03M Buy
3,243
+808
+33% +$259K 0.01% 685
2020
Q4 		$789K Buy
+2,435
New +$674K 0.01% 585
2020
Q3 		– Sell
-1,969
Closed -$476K – 820
2020
Q2 		$476K Buy
+1,969
New +$395K ﹤0.01% 521

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Holocene Advisors's ABMD Position: Q4 2021 in Review

Holocene Advisors sold out of Abiomed Inc (ABMD) in Q4 2021, closing a stake of 634 shares — an estimated $206K sold.

Holocene Advisors first reported a position in ABMD in Q2 2020 and held it in 5 quarters. The position peaked at $1.03M in Q1 2021. 496 funds tracked by Wall St. Rank hold ABMD as of Q4 2021.

  • Holocene Advisors reported no remaining Abiomed Inc position as of Q4 2021 after selling out during the quarter.
  • Holocene Advisors sold 634 Abiomed Inc shares in Q4 2021, an estimated $206K.
  • Holocene Advisors first reported a position in Abiomed Inc in Q2 2020 and held it in 5 quarters.
  • Holocene Advisors's Abiomed Inc position peaked at $1.03M in Q1 2021.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2021.

Based on Holocene Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.